Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadian Factors in Ischemic Stroke Neuroplasticity
NCT05247125Phase 4Recruiting
- Start
- Mar 2022
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in ischemic stroke. Started Mar 2022; status: recruiting.
02
Drugs
melatonin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05247125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05247125.